{"count": 10, "results": [{"_id": "33088426", "pmid": 33088426, "pmcid": "PMC7546754", "title": "Simvastatin is a potential candidate drug in ovarian clear cell carcinomas", "journal": "Oncotarget", "authors": ["Arildsen NS", "Hedenfalk I"], "date": "2020-10-06T00:00:00Z", "doi": "10.18632/oncotarget.27747", "meta_date_publication": "2020 Oct 6", "meta_volume": "11", "meta_issue": "40", "meta_pages": "3660-3674", "score": 50270.938, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ is a potential candidate drug in @<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@ovarian clear cell carcinomas@@@", "citations": {"NLM": "Arildsen NS, Hedenfalk I. Simvastatin is a potential candidate drug in ovarian clear cell carcinomas Oncotarget. 2020 Oct 6;11(40):3660-3674. PMID: 33088426", "BibTeX": "@article{33088426, title={Simvastatin is a potential candidate drug in ovarian clear cell carcinomas}, author={Arildsen NS and Hedenfalk I}, journal={Oncotarget}, volume={11}, number={40}, pages={3660-3674}}"}}, {"_id": "32727400", "pmid": 32727400, "pmcid": "PMC7388525", "title": "Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer", "journal": "BMC Cancer", "authors": ["Göbel A", "Zinna VM", "Dell'Endice S", "Jaschke N", "Kuhlmann JD", "Wimberger P", "Rachner TD"], "date": "2020-07-29T00:00:00Z", "doi": "10.1186/s12885-020-07164-x", "meta_date_publication": "2020 Jul 29", "meta_volume": "20", "meta_issue": "1", "meta_pages": "703", "score": 50254.395, "text_hl": "@CELLLINE_CVCL:1304 @@@IGROV-1@@@ and @CELLLINE_CVCL:0134 @@@A2780@@@ @<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@ovarian cancer@@@ cell lines were treated with increasing concentrations of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@rosuvastatin@@@, or @CHEMICAL_Zoledronic_Acid @CHEMICAL_MESH:D000077211 @@@zoledronic acid@@@. ", "citations": {"NLM": "Göbel A, Zinna VM, Dell'Endice S, Jaschke N, Kuhlmann JD, Wimberger P, Rachner TD. Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer BMC Cancer. 2020 Jul 29;20(1):703. PMID: 32727400", "BibTeX": "@article{32727400, title={Anti-tumor effects of mevalonate pathway inhibition in ovarian cancer}, author={Göbel A and Zinna VM and Dell'Endice S and Jaschke N and Kuhlmann JD and Wimberger P and Rachner TD}, journal={BMC Cancer}, volume={20}, number={1}, pages={703}}"}}, {"_id": "37986175", "pmid": 37986175, "pmcid": "PMC10662458", "title": "Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo", "journal": "J Ovarian Res", "authors": ["Pereira M", "Glogova A", "Haagsma J", "Stewart J", "Shepherd TG", "Petrik J"], "date": "2023-11-20T00:00:00Z", "doi": "10.1186/s13048-023-01307-x", "meta_date_publication": "2023 Nov 20", "meta_volume": "16", "meta_issue": "1", "meta_pages": "218", "score": 50253.266, "text_hl": "In vivo, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ induced @<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@ovarian cancer disease@@@ regression through decreased primary @<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@ovarian tumor@@@ weight and increased apoptosis. ", "citations": {"NLM": "Pereira M, Glogova A, Haagsma J, Stewart J, Shepherd TG, Petrik J. Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo J Ovarian Res. 2023 Nov 20;16(1):218. PMID: 37986175", "BibTeX": "@article{37986175, title={Mutant p53 murine oviductal epithelial cells induce progression of high-grade serous carcinoma and are most sensitive to simvastatin therapy in vitro and in vivo}, author={Pereira M and Glogova A and Haagsma J and Stewart J and Shepherd TG and Petrik J}, journal={J Ovarian Res}, volume={16}, number={1}, pages={218}}"}}, {"_id": "37323625", "pmid": 37323625, "pmcid": "PMC10266906", "title": "Repurposing Drugs in Controlling Recurrent Platinum-Resistant Clear-Cell Ovarian Cancer", "journal": "Case Rep Oncol Med", "authors": ["Sinsuwan W", "Norchai P"], "date": "2023-06-07T00:00:00Z", "doi": "10.1155/2023/2079654", "meta_date_publication": "2023", "meta_volume": "2023", "meta_issue": "", "meta_pages": "2079654", "score": 50245.305, "text_hl": "Repurposing Drugs in Controlling Recurrent @CHEMICAL_Platinum @CHEMICAL_MESH:D010984 @@@Platinum@@@-Resistant @<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@Clear-Cell Ovarian Cancer@@@", "citations": {"NLM": "Sinsuwan W, Norchai P. Repurposing Drugs in Controlling Recurrent Platinum-Resistant Clear-Cell Ovarian Cancer Case Rep Oncol Med. 2023;2023():2079654. PMID: 37323625", "BibTeX": "@article{37323625, title={Repurposing Drugs in Controlling Recurrent Platinum-Resistant Clear-Cell Ovarian Cancer}, author={Sinsuwan W and Norchai P}, journal={Case Rep Oncol Med}, volume={2023}, pages={2079654}}"}}, {"_id": "33070276", "pmid": 33070276, "title": "Statins decrease the expression of c-Myc protein in cancer cell lines.", "journal": "Mol Cell Biochem", "authors": ["Rao PS", "Rao US"], "date": "2021-02-01T00:00:00Z", "doi": "10.1007/s11010-020-03940-2", "meta_date_publication": "2021 Feb", "meta_volume": "476", "meta_issue": "2", "meta_pages": "743-755", "score": 50231.125, "text_hl": "Here, we carried out a comprehensive analysis of the effects of three statins, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@, and @CHEMICAL_Lovastatin @CHEMICAL_MESH:D008148 @@@lovastatin@@@, on six different @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ cell lines that include a @GENE_ABCB1 @GENE_5243 @@@P-glycoprotein@@@-expressing, multidrug resistant variant of an @<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@ovarian cancer@@@ cell line. ", "citations": {"NLM": "Rao PS, Rao US. Statins decrease the expression of c-Myc protein in cancer cell lines. Mol Cell Biochem. 2021 Feb;476(2):743-755. PMID: 33070276", "BibTeX": "@article{33070276, title={Statins decrease the expression of c-Myc protein in cancer cell lines.}, author={Rao PS and Rao US}, journal={Mol Cell Biochem}, volume={476}, number={2}, pages={743-755}}"}}, {"_id": "23402903", "pmid": 23402903, "title": "Preclinical evaluation of statins as a treatment for ovarian cancer.", "journal": "Gynecol Oncol", "authors": ["Robinson E", "Nandi M", "Wilkinson LL", "Arrowsmith DM", "Curtis AD", "Richardson A"], "date": "2013-05-01T00:00:00Z", "doi": "10.1016/j.ygyno.2013.02.003", "meta_date_publication": "2013 May", "meta_volume": "129", "meta_issue": "2", "meta_pages": "417-24", "score": 50068.59, "text_hl": "Sensitivity to @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ was also evaluated in @<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@ovarian cancer@@@ spheroids. ", "citations": {"NLM": "Robinson E, Nandi M, Wilkinson LL, Arrowsmith DM, Curtis AD, Richardson A. Preclinical evaluation of statins as a treatment for ovarian cancer. Gynecol Oncol. 2013 May;129(2):417-24. PMID: 23402903", "BibTeX": "@article{23402903, title={Preclinical evaluation of statins as a treatment for ovarian cancer.}, author={Robinson E and Nandi M and Wilkinson LL and Arrowsmith DM and Curtis AD and Richardson A}, journal={Gynecol Oncol}, volume={129}, number={2}, pages={417-24}}"}}, {"_id": "29848667", "pmid": 29848667, "title": "Simvastatin interferes with cancer 'stem-cell' plasticity reducing metastasis in ovarian cancer.", "journal": "Endocr Relat Cancer", "authors": ["Kato S", "Liberona MF", "Cerda-Infante J", "Sánchez M", "Henríquez J", "Bizama C", "Bravo ML", "Gonzalez P", "Gejman R", "Brañes J", "García K", "Ibañez C", "Owen GI", "Roa JC", "Montecinos V", "Cuello MA"], "date": "2018-10-01T00:00:00Z", "doi": "10.1530/ERC-18-0132", "meta_date_publication": "2018 Oct", "meta_volume": "25", "meta_issue": "10", "meta_pages": "821-836", "score": 50059.156, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ interferes with @DISEASE_Neoplasms @DISEASE_MESH:D009369 @@@cancer@@@ 'stem-cell' plasticity reducing @DISEASE_Neoplasm_Metastasis @DISEASE_MESH:D009362 @@@metastasis@@@ in @<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@ovarian cancer@@@.", "citations": {"NLM": "Kato S, Liberona MF, Cerda-Infante J, Sánchez M, Henríquez J, Bizama C, Bravo ML, Gonzalez P, Gejman R, Brañes J, García K, Ibañez C, Owen GI, Roa JC, Montecinos V, Cuello MA. Simvastatin interferes with cancer 'stem-cell' plasticity reducing metastasis in ovarian cancer. Endocr Relat Cancer. 2018 Oct;25(10):821-836. PMID: 29848667", "BibTeX": "@article{29848667, title={Simvastatin interferes with cancer 'stem-cell' plasticity reducing metastasis in ovarian cancer.}, author={Kato S and Liberona MF and Cerda-Infante J and Sánchez M and Henríquez J and Bizama C and Bravo ML and Gonzalez P and Gejman R and Brañes J and García K and Ibañez C and Owen GI and Roa JC and Montecinos V and Cuello MA}, journal={Endocr Relat Cancer}, volume={25}, number={10}, pages={821-836}}"}}, {"_id": "26503475", "pmid": 26503475, "pmcid": "PMC4808044", "title": "The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer", "journal": "Oncotarget", "authors": ["Stine JE", "Guo H", "Sheng X", "Han X", "Schointuch MN", "Gilliam TP", "Gehrig PA", "Zhou C", "Bae-Jump VL"], "date": "2016-01-05T00:00:00Z", "doi": "10.18632/oncotarget.5834", "meta_date_publication": "2016 Jan 5", "meta_volume": "7", "meta_issue": "1", "meta_pages": "946-60", "score": 50058.773, "text_hl": "...@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ increased apoptosis in @<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@ovarian cancer@@@ cells", "citations": {"NLM": "Stine JE, Guo H, Sheng X, Han X, Schointuch MN, Gilliam TP, Gehrig PA, Zhou C, Bae-Jump VL. The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer Oncotarget. 2016 Jan 5;7(1):946-60. PMID: 26503475", "BibTeX": "@article{26503475, title={The HMG-CoA reductase inhibitor, simvastatin, exhibits anti-metastatic and anti-tumorigenic effects in ovarian cancer}, author={Stine JE and Guo H and Sheng X and Han X and Schointuch MN and Gilliam TP and Gehrig PA and Zhou C and Bae-Jump VL}, journal={Oncotarget}, volume={7}, number={1}, pages={946-60}}"}}, {"_id": "21109955", "pmid": 21109955, "title": "Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma.", "journal": "Oncol Rep", "authors": ["Matsuura M", "Suzuki T", "Suzuki M", "Tanaka R", "Ito E", "Saito T"], "date": "2011-01-01T00:00:00Z", "meta_date_publication": "2011 Jan", "meta_volume": "25", "meta_issue": "1", "meta_pages": "41-7", "score": 50058.71, "text_hl": "In this study, we investigated the effects of @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ on @<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@ovarian clear cell carcinoma@@@ (@<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@OCCC@@@) cells in vitro and in vivo and elucidated the mechanism of drug action. ", "citations": {"NLM": "Matsuura M, Suzuki T, Suzuki M, Tanaka R, Ito E, Saito T. Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma. Oncol Rep. 2011 Jan;25(1):41-7. PMID: 21109955", "BibTeX": "@article{21109955, title={Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma.}, author={Matsuura M and Suzuki T and Suzuki M and Tanaka R and Ito E and Saito T}, journal={Oncol Rep}, volume={25}, number={1}, pages={41-7}}"}}, {"_id": "21874229", "pmid": 21874229, "title": "Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and beta1 integrin.", "journal": "Int J Oncol", "authors": ["Wagner BJ", "Löb S", "Lindau D", "Hörzer H", "Gückel B", "Klein G", "Glatzle J", "Rammensee HG", "Brücher BL", "Königsrainer A"], "date": "2011-12-01T00:00:00Z", "doi": "10.3892/ijo.2011.1167", "meta_date_publication": "2011 Dec", "meta_volume": "39", "meta_issue": "6", "meta_pages": "1593-600", "score": 50053.74, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ significantly reduced the adhesion of all @<m>DISEASE_Ovarian_Neoplasms</m> @DISEASE_MESH:D010051 @@@ovarian cancer@@@ cells and @CELLLINE_CVCL:0320 @@@HT29@@@ to HMCs (P<=0.001). ", "citations": {"NLM": "Wagner BJ, Löb S, Lindau D, Hörzer H, Gückel B, Klein G, Glatzle J, Rammensee HG, Brücher BL, Königsrainer A. Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and beta1 integrin. Int J Oncol. 2011 Dec;39(6):1593-600. PMID: 21874229", "BibTeX": "@article{21874229, title={Simvastatin reduces tumor cell adhesion to human peritoneal mesothelial cells by decreased expression of VCAM-1 and beta1 integrin.}, author={Wagner BJ and Löb S and Lindau D and Hörzer H and Gückel B and Klein G and Glatzle J and Rammensee HG and Brücher BL and Königsrainer A}, journal={Int J Oncol}, volume={39}, number={6}, pages={1593-600}}"}}]}